Urine prohibitin identified as a prognostic biomarker in Wilms’ tumor
Oral immunotherapy drug is first of its kind
Non-fusion technique shows early promise
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New findings have clinical implications for myelomeningocele management
Small numbers of heterogeneous patients complicate outcomes measurement in this highly nuanced field
Successful transition of care for patients with pediatric cholestatic liver disease is multidisciplinary
The effect of mefloquine on acute leukemia cell lines
Recognizing the distinctive clinical picture
Teens express fears and seek support but are less likely than adults to feel helpless
Advertisement
Advertisement